Even mTORC1 inhibition in the proximal convoluted tubule has been strongly implicated in the renoprotective effects of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in diabetic nephropathy [136]. Here, SLC5A2 is linked to diabetic kidney disease.